2026年Q2医药展望:多款新药迎审批节点,精神与代谢领域将有关键数据读出-Q2 2026 Outlook Report BIOMEDTRACKER.pptx

2026年Q2医药展望:多款新药迎审批节点,精神与代谢领域将有关键数据读出-Q2 2026 Outlook Report BIOMEDTRACKER.pptx

Q22026

OutlookReport

May2026

Broughttoyouby:

TableofContents

AbouttheAuthor3

ExecutiveSummary3

Disclaimer3

DataAnalysis………………….4

Drugs7

RegulatoryApprovals7

OclaizforAcromegaly7

CTx-1301forAttentionDeficitHyperactivityDisorder(ADHD)8

Nilop

文档评论(0)

1亿VIP精品文档

相关文档